Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Out-licensing
- View
LPCN 1019: Immunosuppressant ANDA opportunity
Immunosupressant product, bioequivalent to reference product
Full description
LPCN 1019 is being developed as an immunosuppressant. It has completed a pre-liminary bio-equivalence study.
Development status
Phase I
Patent information
Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions (US 6,569,463; priority date November 23, 1999)
Type of business relationship sought
Lipocine seeks any partners with the strong marketing, manufacturing infrastructure and to support further development.
Licensing contact
Jerry Simmons
Corporate Business Development Officer
Corporate Business Development Officer
Company details
Lipocine
Lipocine develop branded products using its proprietary drug delivery technologies. They provide discovery and delivery support for challenging drugs. They issued 14 patents and corporate partnerships
Lipocine develop branded products using its proprietary drug delivery technologies. They provide discovery and delivery support for challenging drugs. They issued 14 patents and corporate partnerships
Related reports
Are you looking for reports related to this particular subject. Our Reports section is the best place to start.
Related items
Related categories
- Industry sector
- Drug delivery
- Drug delivery / Oral solid
- Pharmaceutical
- Therapeutic target
- Immune related disorders
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us